Out with the old, in with the new: New Haven
We’re building a world-class research and development center in New Haven, CT, which offers unique benefits for Arvinas and for our employees. New Haven is emerging as a thriving biotech hub - 40 to 50 new biotech ventures have emerged in the area in the past 10 years alone. We’re growing and the world is recognizing the incredible benefits of biotech in New Haven.
According to Yale’s Office of Cooperative Research, New Haven startups based on Yale intellectual property have raised more than $1 billion in venture capital funding and $11 billion in public markets in 2018.
Not only does New Haven offer a rich environment for research and biotech innovation, it also affords residents rich arts and culture, desirable quality of life, and easy access to other major Northeast cities. And did we mention the affordability and lack of traffic headaches associated with other major biotech hubs?